まとめ
青い光療法は,黄のラットでビリルビンを同位体に変換し,光療法を受ける幼児でも発生する可能性が高いプロセスです. このイソメリゼーションは,ビリルビンの排泄を助け,体内の蓄積を防止します.
科学分野:
- バイオケミストリー バイオケミストリー
- フォトケミストリー フォトケミストリー
- 新生児医学 新生児医学
背景:
- 黄は新生児の一般的な疾患で,ビリルビンの濃度が上昇することが特徴です.
- ビリルビンの排泄は,有毒物質の蓄積を防ぐために非常に重要です.
- 分子内水素結合は,結合していないビリルビンの直接的排泄を妨げます.
研究 の 目的:
- 青い光によるビリルビンの光化学的変換を調査する.
- 光に曝された黄の被験者におけるビリルビンの分泌のメカニズムを理解するために.
- 光療法の有効性におけるビリルビンのイソメリゼーションの役割を調査する.
主な方法:
- 実験は青い光にさらされた黄症のラットで実施した.
- ビリルビンの同位体形成と輸送の分析.
- 胆汁の排泄経路の調査.
主要な成果:
- 青い光は,ネズミの皮膚でビリルビニをメタステーブルな幾何学イソマーに変換する.
- これらの同位体は血液で運ばれ,胆汁で分泌される.
- この発見は,光療法中の黄症の乳児における同様のメカニズムを示唆している.
結論:
- 光療法の青い光は,イソメリゼーションを通してビリルビンの分泌を促進します.
- 効率的なビリルビンの除去には,より極性派生体への代謝が必要である.
- このプロセスを理解することは,新生児の黄治療を最適化するための鍵です.
さらに関連する動画
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
関連する概念動画
Drug Elimination: Non-Renal Routes
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
Bile
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Drug Excretion: Miscellaneous Routes
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
